Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iressa in upper aerodigestive tract carcinomas
NCT00169221Phase 2Terminated
- Sponsor
- GORTEC
- Start
- Sep 2005
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in head and neck cancer (HNC), sponsored by GORTEC. Started Sep 2005; status: terminated.
02
Drugs
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on NCT00169221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00169221.